Kun Chen

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 4

Top Topics

Signaling Pathway

Inflammatory Response

Candida Albicans

Top Venues

Oxidative medicine and cellular longevity

OncoTargets and therapy

EMBO molecular medicine

Guizhou University (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Guizhou University Sep 01 2015

China

PHD :: College of Life Science； Key Laboratory of Animal GeneticsBreeding and Production in the Pleteau Mountains Region,Ministry of Education

Guizhou Medical University Sep 01 2007 - Jul 01 2010

China

MSC :: Parasitology department

Publications

Hongyan Lu, Xifeng Sun, Min Jia, Fa Sun, Jianguo Zhu, Xiaolong Chen, Kun Chen, Kehua Jiang
Rosiglitazone Suppresses Renal Crystal Deposition by Ameliorating Tubular Injury Resulted from Oxidative Stress and Inflammatory Response via Promoting the Nrf2/HO-1 Pathway and Shifting Macrophage Polarization. Oxidative medicine and cellular longevity 2021 (2021)
Shuhang Wang, Kun Chen, Qi Lei, Peiwen Ma, Andy Qingan Yuan, Yong Zhao, Youwei Jiang, Hong Fang, Shujun Xing, Yuan Fang, Ning Jiang, Huilei Miao, Minghui Zhang, Shujun Sun, Zicheng Yu, Wei Tao, Qi Zhu, Yingjie Nie, Ning Li
The state of the art of bispecific antibodies for treating human malignancies. EMBO molecular medicine 13 (9) (2021)
Bicheng Jin, Dongfang Jin, Zhaozhen Zhuo, Bo Zhang, Kun Chen
MiR-1224-5p Activates Autophagy, Cell Invasion and Inhibits Epithelial-to-Mesenchymal Transition in Osteosarcoma Cells by Directly Targeting PLK1 Through PI3K/AKT/mTOR Signaling Pathway. OncoTargets and therapy 13 (2020)
Kun Chen, Hou-Qiang Xu, Jiafu Zhao
Bloom Syndrome Protein Activates AKT and PRAS40 in Prostate Cancer Cells. Oxidative medicine and cellular longevity 2019 (2019)